102 related articles for article (PubMed ID: 3499908)
1. [Hemodynamic effects of a new calcium antagonist, bepridil, in patients with coronary artery disease].
Haerer VW; Stauch M
Arzneimittelforschung; 1987 Jul; 37(7):829-31. PubMed ID: 3499908
[TBL] [Abstract][Full Text] [Related]
2. Lack of effects of trimetazidine on systemic hemodynamics in patients with coronary artery disease: a placebo-controlled study.
Pornin M; Harpey C; Allal J; Sellier P; Ourbak P
Clin Trials Metaanal; 1994 Apr; 29(1):49-56. PubMed ID: 10150185
[TBL] [Abstract][Full Text] [Related]
3. [Hemodynamic effects of the new calcium antagonist nimodipine in normal and increased blood pressure].
Engberding R; Bender F; Gülker H; Specker E; Molinski M
Z Kardiol; 1984 Aug; 73(8):498-503. PubMed ID: 6495809
[TBL] [Abstract][Full Text] [Related]
4. [Isradipine (PN 200-110), a new dihydropyridine calcium antagonist with slight negative inotropic properties in comparison with nifedipine].
Mauser M; Voelker W; Karsch KR
Z Kardiol; 1988 Jun; 77(6):373-7. PubMed ID: 2975095
[TBL] [Abstract][Full Text] [Related]
5. Acute hemodynamic and antiischemic properties of intravenous bepridil in coronary artery disease.
Remme WJ; Kruyssen DA; Van Hoogenhuyze DC; Hofman B; Krauss XH; Storm CJ
Am J Cardiol; 1989 Mar; 63(11):670-5. PubMed ID: 2784281
[TBL] [Abstract][Full Text] [Related]
6. Cardiovascular actions after intravenous and intracoronary administration of the slow channel blocker bepridil.
Verdouw PD; Scheffer MG
Arzneimittelforschung; 1984; 34(1):21-5. PubMed ID: 6608356
[TBL] [Abstract][Full Text] [Related]
7. [Does chronic oral treatment with beta-receptor blockers have an effect on positive inotropic therapy of coronary patients with adrenaline after extracorporeal circulation?].
Günnicker M; Brinkmann M; Freund U; Piotrowski J; Schieffer M; Velser U
Herz; 1995 Dec; 20(6):399-411. PubMed ID: 8582699
[TBL] [Abstract][Full Text] [Related]
8. Effects on hemodynamics and left ventricular ejection fraction of intravenous bepridil for impaired left ventricular function secondary to coronary artery disease.
Josephson MA; Mody T; Coyle K; Singh BN
Am J Cardiol; 1987 Jul; 60(1):44-9. PubMed ID: 3496779
[TBL] [Abstract][Full Text] [Related]
9. [Bepridil: hemodynamic and coronary effects on normal and/or ischemic myocardium in dogs (author's transl)].
Berdeaux A; Kantelip JP; Eschalier A; Giudicelli JF; Duchene-Marullaz P
J Pharmacol; 1980; 11(4):391-409. PubMed ID: 6970858
[TBL] [Abstract][Full Text] [Related]
10. [Hemodynamic effects of nisoldipine (Bay k 5552), a calcium antagonist, in coronary surgery patients].
Kling D; Boldt J; Moosdorf R; von Bormann B; Hempelmann G
Anaesthesist; 1986 Oct; 35(10):595-603. PubMed ID: 3789388
[TBL] [Abstract][Full Text] [Related]
11. Hemodynamic effects of intravenous bepridil in patients with normal left ventricular function.
Alpert JS; Benotti JR; Brady PM; McCue JE; Weiner BH; Ockene IS
Am J Cardiol; 1985 Mar; 55(7):20C-24C. PubMed ID: 3872053
[TBL] [Abstract][Full Text] [Related]
12. [Hemodynamic and coronary changes induced by various slow-channel inhibitors in chronic coronary insufficiency: nifedipine, verapamil and bepridil].
Merillon JP; Duffloux MA; Eustigneff T; Pansard Y; Guiomard A; Zygelman M; Aumont MC; Gourgon R
Therapie; 1981; 36(2):123-34. PubMed ID: 6270840
[No Abstract] [Full Text] [Related]
13. Hemodynamic changes during posterior vessel off-pump coronary artery bypass: comparison between deep pericardial sutures and vacuum-assisted apical suction device.
Chang WI; Kim KB; Kim JH; Ham BM; Kim YL
Ann Thorac Surg; 2004 Dec; 78(6):2057-62. PubMed ID: 15561035
[TBL] [Abstract][Full Text] [Related]
14. Reduction of myocardial infarct size in rats under the effect of bepridil.
Richard V; de Leiris J
Adv Myocardiol; 1985; 6():563-72. PubMed ID: 3873103
[TBL] [Abstract][Full Text] [Related]
15. Hemodynamic assessment of intravenous bepridil administration in ischemic heart disease.
Tamari I; Borer JS; Moses JW; Goldberg HL; Fisher J; Wallis JB; Halle A
Am J Cardiol; 1985 Mar; 55(7):25C-29C. PubMed ID: 3872054
[TBL] [Abstract][Full Text] [Related]
16. [Comparison of anti-ischemic effect of bepridil and diltiazem evaluated by exercise test in patients with coronary disease. A multicenter study. Groupe d'Investigateurs].
Sellier P; Quilliet L
Ann Cardiol Angeiol (Paris); 1997 Nov; 46(9):602-8. PubMed ID: 9538375
[TBL] [Abstract][Full Text] [Related]
17. Hemodynamic actions on alinidine during exercise in patients with coronary artery disease.
Löllgen H; Just H; Wollschläger H; Kersting F
Z Kardiol; 1981 May; 70(5):425-8. PubMed ID: 7269729
[TBL] [Abstract][Full Text] [Related]
18. Electrophysiological profile of bepridil, a new anti-anginal drug with calcium blocking properties.
Flammang D; Waynberger M; Jansen FH; Paillet R; Coumel P
Eur Heart J; 1983 Sep; 4(9):657-54. PubMed ID: 6605854
[TBL] [Abstract][Full Text] [Related]
19. Hemodynamic effects of the calcium channel blocker pranidipine on exercise-induced angina.
Nishinaka Y; Yokota M; Watanabe M; Sobue T; Iwase M; Ukai M; Ando A; Nagata K; Saito H
Int J Clin Pharmacol Ther; 1994 Oct; 32(10):542-9. PubMed ID: 7834162
[TBL] [Abstract][Full Text] [Related]
20. Nicardipine, nitrendipine, and bepridil: new calcium antagonists for cardiovascular disorders.
Hasegawa GR
Clin Pharm; 1988 Feb; 7(2):97-108. PubMed ID: 3280222
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
